STICH II Trial: Which treatment is the best for brain haemorhage?
The STICH II Trial is a surgical trial in sponatenous lobar Intracerebral Haemorrhage or ICH. The Trial has a target of 600 patients to reach before 31st May 2012. Currently over 100 hospitals worldwide are participating, including 18 in the UK. If you are registered and would like some promotional material to distribute to your colleagues / a member of the STICH II team to visit your site, please do send an email to email@example.com
STICH was a prospective randomised trial to compare early surgery with initial conservative treatment for patients with spontaneous supratentorial intracerebral haemorrhage.
The link for the STICH II website is: http://research.ncl.ac.uk/stich/